Evaluating differences in whole blood, serum, and urine screening tests for zika virus, Puerto Rico, USA, 2016

Asher Y. Rosinger, Samantha M. Olson, Sascha R. Ellington, Janice Perez-Padilla, Regina M. Simeone, Caitlin S. Pedati, Betsy A. Schroeder, Gilberto A. Santiago, Freddy A. Medina, Jorge L. Muñoz-Jordán, Laura E. Adams, Romeo R. Galang, Miguel Valencia-Prado, Sonia Bakkour, Candimar Colón, Mary Goodwin, Dana Meaney-Delman, Jennifer S. Read, Lyle R. Petersen, Denise J. JamiesonCarmen C. Deseda, Margaret A. Honein, Brenda Rivera-García, Carrie K. Shapiro-Mendoza

Research output: Contribution to journalReview articlepeer-review

Abstract

We evaluated nucleic acid amplifi cation testing (NAAT) for Zika virus on whole-blood specimens compared with NAAT on serum and urine specimens among asymptomatic pregnant women during the 2015-2016 Puerto Rico Zika outbreak. Using NAAT, more infections were detected in serum and urine than in whole blood specimens.

Original languageEnglish (US)
Pages (from-to)1505-1508
Number of pages4
JournalEmerging infectious diseases
Volume27
Issue number5
DOIs
StatePublished - May 2021

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Evaluating differences in whole blood, serum, and urine screening tests for zika virus, Puerto Rico, USA, 2016'. Together they form a unique fingerprint.

Cite this